Clinical Trial Update: Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis

View source ↗

Summary

This document reports the long-term investigation of adalimumab (Humira) in patients with rheumatoid arthritis, including results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2015-06-10